Phase 1, double-blind, placebo-controlled, two-center, pharmacokinetic study evaluating the systemic absorption and safety of OMS201 [ketoprofen/nifedipine] in subjects undergoing ureteroscopic treatment of unilateral ureteral- or renal pelvis-located stones

Trial Profile

Phase 1, double-blind, placebo-controlled, two-center, pharmacokinetic study evaluating the systemic absorption and safety of OMS201 [ketoprofen/nifedipine] in subjects undergoing ureteroscopic treatment of unilateral ureteral- or renal pelvis-located stones

Completed
Phase of Trial: Phase I

Latest Information Update: 05 May 2010

At a glance

  • Drugs Ketoprofen/nifedipine (Primary)
  • Indications Postoperative pain
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 05 May 2010 Actual number of patients (11) added as reported by ClinicalTrials.gov record.
    • 05 May 2010 Actual end date (1 Sep 2008) added as reported by ClinicalTrials.gov record.
    • 15 Dec 2008 Status changed from recruiting to completed according to a Omeros media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top